Docosahexaenoic acid stimulates tube formation in first trimester trophoblast cells, HTR8/SVneo

Placenta

Volumn 32, Issue 9, 2011, Pages 626-632

  Johnsen, G M ^a   Basak, S ^a   Weedon Fekjaer M S ^a   Staff, A C ^a,b   Duttaroy, A K ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Angiogenesis; ANGPTL4; Docosahexaenoic acid; Fatty acids; HTR8 SVneo cells; Placenta; TIMP 1; Trophoblast; Tube formation; VEGF

Indexed keywords

[2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; ANGIOPOIETIN; ANGIOPOIETIN LIKE PROTEIN 4; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; MESSENGER RNA; OLEIC ACID; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN INHIBITOR;

ANGIOGENESIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS DEVELOPMENT; FIRST TRIMESTER PREGNANCY; GENE EXPRESSION; LIPID METABOLISM; NEURAL TUBE; PRIORITY JOURNAL; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; TROPHOBLAST;

ARACHIDONIC ACID; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN; DOCOSAHEXAENOIC ACIDS; DRUG COMBINATIONS; EICOSAPENTAENOIC ACID; FATTY ACIDS; FEMALE; HUMANS; LAMININ; NEOVASCULARIZATION, PHYSIOLOGIC; OLEIC ACID; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PROTEOGLYCANS; TROPHOBLASTS;

EID: 80052260597     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2011.06.009     Document Type: Article

References (39)

1. E. Staun-Ram, and E. Shalev Human trophoblast function during the implantation process Reprod Biol Endocrinol 3 2005 56
2. I. Caniggia, J. Winter, S.J. Lye, and M. Post Oxygen and placental development during the first trimester: implications for the pathophysiology of pre-eclampsia Placenta 21 Suppl. A 2000 S25 S30
3. G.S. Whitley, and J.E. Cartwright Cellular and molecular regulation of spiral artery remodelling: lessons from the cardiovascular field Placenta 31 6 2010 465 474
4. I.B. Chung, F.D. Yelian, F.M. Zaher, B. Gonik, M.I. Evans, and M.P. Diamond Expression and regulation of vascular endothelial growth factor in a first trimester trophoblast cell line Placenta 21 4 2000 320 324 (Pubitemid 30364865)
5. S. Shinkaruk, M. Bayle, G. Lain, and G. Deleris Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy Curr Med Chem Anticancer Agents 3 2 2003 95 117 (Pubitemid 36221732)
6. A.M. Sharkey, J.C. Cooper, J.R. Balmforth, J. McLaren, D.E. Clark, and D.S. Charnock-Jones Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia Eur J Clin Invest 26 12 1996 1182 1185
7. V.H. Shore, T.H. Wang, C.L. Wang, R.J. Torry, M.R. Caudle, and D.S. Torry Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast Placenta 18 8 1997 657 665 (Pubitemid 27448423)
8. J.C. Cooper, A.M. Sharkey, D.S. Charnock-Jones, C.R. Palmer, and S.K. Smith VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia Br J Obstet Gynaecol 103 12 1996 1191 1196 (Pubitemid 26402883)
9. O. Wendling, P. Chambon, and M. Mark Retinoid X receptors are essential for early mouse development and placentogenesis Proc Natl Acad Sci U S A 96 2 1999 547 551 (Pubitemid 29061245)
10. A. Tarrade, K. Schoonjans, L. Pavan, J. Auwerx, C. Rochette-Egly, and D. Evain-Brion PPARgamma/RXRalpha heterodimers control human trophoblast invasion J Clin Endocrinol Metab 86 10 2001 5017 5024 (Pubitemid 33020558)
11. A. Aljada, L. O'Connor, Y.Y. Fu, and S.A. Mousa PPAR gamma ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis Angiogenesis 11 4 2008 361 367
12. D. Panigrahy, A. Kaipainen, S. Huang, C.E. Butterfield, C.M. Barnes, and M. Fannon PPARalpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition Proc Natl Acad Sci U S A 105 3 2008 985 990 (Pubitemid 351282068)
13. L. Piqueras, A.R. Reynolds, K.M. Hodivala-Dilke, A. Alfranca, J.M. Redondo, and T. Hatae Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis Arterioscler Thromb Vasc Biol 27 1 2007 63 69 (Pubitemid 46370477)
14. T. Fournier, V. Tsatsaris, K. Handschuh, and D. Evain-Brion PPARs and the placenta Placenta 28 2-3 2007 65 76 (Pubitemid 44929358)
15. A.K. Duttaroy Transport of fatty acids across the human placenta: a review Prog Lipid Res 48 1 2009 52 61
16. C.H. Graham, T.S. Hawley, R.G. Hawley, J.R. MacDougall, R.S. Kerbel, and N. Khoo Establishment and characterization of first trimester human trophoblast cells with extended lifespan Exp Cell Res 206 2 1993 204 211 (Pubitemid 23212937)
17. D. Benaitreau, E. Dos Santos, M.C. Leneveu, N. Alfaidy, J.J. Feige, and P. de Mazancourt Effects of adiponectin on human trophoblast invasion J Endocrinol 207 1 2010 45 53
18. I. Arnaoutova, J. George, H.K. Kleinman, and G. Benton The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art Angiogenesis 12 3 2009 267 274
19. A.J. Moyes, D. Maldonado-Perez, G.A. Gray, and F.C. Denison Enhanced angiogenic capacity of human umbilical vein endothelial cells from women with preeclampsia Reprod Sci 18 4 2011 374 382
20. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Methods 25 4 2001 402 408 (Pubitemid 34164012)
21. A.K. Duttaroy, D. Crozet, J. Taylor, and M.J. Gordon Acyl-CoA thioesterase activity in human placental choriocarcinoma (BeWo), cells: effects of fatty acids Prostaglandins Leukot Essent Fatty Acids 68 1 2003 43 48 (Pubitemid 36197485)
22. J.F. Porter, S. Shen, and D.T. Denhardt Tissue inhibitor of metalloproteinase-1 stimulates proliferation of human cancer cells by inhibiting a metalloproteinase Br J Cancer 90 2 2004 463 470 (Pubitemid 38250646)
23. Y. Lu, S. Liu, S. Zhang, G. Cai, H. Jiang, and H. Su Tissue inhibitor of metalloproteinase-1 promotes NIH3T3 fibroblast proliferation by activating p-Akt and cell cycle progression Mol Cell 31 3 2011 225 230
24. Z. Khan, N. Khan, R.P. Tiwari, N.K. Sah, G.B. Prasad, and P.S. Bisen Biology of Cox-2: an application in cancer therapeutics Curr Drug Targets 2011
25. N. Ferrara Vascular endothelial growth factor as a target for anticancer therapy Oncologist 9 Suppl. 1 2004 2 10 (Pubitemid 38747842)
26. L. Spencer, C. Mann, M. Metcalfe, M. Webb, C. Pollard, and D. Spencer The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential Eur J Cancer 45 12 2009 2077 2086
27. G. Calviello, F. Di Nicuolo, S. Gragnoli, E. Piccioni, S. Serini, and N. Maggiano n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway Carcinogenesis 25 12 2004 2303 2310 (Pubitemid 39625169)
28. Q. Lin, S.E. Ruuska, N.S. Shaw, D. Dong, and N. Noy Ligand selectivity of the peroxisome proliferator-activated receptor alpha Biochemistry 38 1 1999 185 190 (Pubitemid 29035685)
29. A.M. de Urquiza, S. Liu, M. Sjoberg, R.H. Zetterstrom, W. Griffiths, and J. Sjovall Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain Science 290 5499 2000 2140 2144 (Pubitemid 32001593)
30. M. Gottlicher, A. Demoz, D. Svensson, P. Tollet, R.K. Berge, and J.A. Gustafsson Structural and metabolic requirements for activators of the peroxisome proliferator-activated receptor Biochem Pharmacol 46 12 1993 2177 2184 (Pubitemid 24012309)
31. N. Salem Jr., B. Litman, H.Y. Kim, and K. Gawrisch Mechanisms of action of docosahexaenoic acid in the nervous system Lipids 36 9 2001 945 959 (Pubitemid 33065196)
32. R. Uauy, D.R. Hoffman, P. Peirano, D.G. Birch, and E.E. Birch Essential fatty acids in visual and brain development Lipids 36 9 2001 885 895 (Pubitemid 33065189)
33. Y. Akagi, W. Liu, B. Zebrowski, K. Xie, and L.M. Ellis Regulation of vascular endothelial growth factor expression in human colon cancer by insulin-like growth factor-I Cancer Res 58 17 1998 4008 4014 (Pubitemid 28405661)
34. L.M. Hermann, M. Pinkerton, K. Jennings, L. Yang, A. Grom, and D. Sowders Angiopoietin-like-4 is a potential angiogenic mediator in arthritis Clin Immunol 115 1 2005 93 101 (Pubitemid 40616175)
35. O. Gealekman, A. Burkart, M. Chouinard, S.M. Nicoloro, J. Straubhaar, and S. Corvera Enhanced angiogenesis in obesity and in response to PPARgamma activators through adipocyte VEGF and ANGPTL4 production Am J Physiol Endocrinol Metab 295 5 2008 E1056 E1064
36. H. Staiger, C. Haas, J. Machann, R. Werner, M. Weisser, and F. Schick Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans Diabetes 58 3 2009 579 589
37. T. Yamada, N. Ozaki, Y. Kato, Y. Miura, and Y. Oiso Insulin downregulates angiopoietin-like protein 4 mRNA in 3T3-L1 adipocytes Biochem Biophys Res Commun 347 4 2006 1138 1144 (Pubitemid 44118232)
38. M.A. Lafleur, M.M. Handsley, V. Knäuper, G. Murphy, and D.R. Edwards Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs) J Cell Sci 115 2002 3427 3438 (Pubitemid 34994032)
39. M. Klingler, A. Blaschitz, C. Campoy, A. Cano, A.M. Molloy, and J.M. Scott The effect of docosahexaenoic acid and folic acid supplementation on placental apoptosis and proliferation Br J Nutr 96 1 2006 182 190 (Pubitemid 44160913)